Results 131 to 140 of about 18,161,920 (183)

Investigation of 2-Hydroxypropyl-β-Cyclodextrin Treatment in a Neuronal-Like Cell Model of Niemann-Pick Type C Using Quantitative Proteomics. [PDF]

J Am Soc Mass Spectrom, 2023
Cougnoux A, Pergande MR, Serna-Perez F, Cologna SM.   +3 more
europepmc   +1 more source

Formulation of Berberine Hydrochloride and Hydroxypropyl-β-Cyclodextrin Inclusion Complex with Enhanced Dissolution and Reduced Bitterness

, 2013
Purpose: To prepare and characterize inclusion complex of berberine hydrochloride with hydroxypropyl-β-cyclodextrin in order to achieve enhanced solubility and reduced bitterness of the former.
Shang, Xiaojun, Ma, Suying, Wang, Yong, Yan, Fulin   +3 more
core   +1 more source

Solubilization of Hydroxypropyl-β-Cyclodextrin on Cholesterol in Aqueous Solution

, 2014
Hydroxypropyl-β-Cyclodextrin (HP-β-CD), prepared via reaction of β-Cyclodextrin (β-CD) and propylene oxide (PO), is utilized to research solubilization of HP-β-CD on cholesterol in aqueous solution. HP-β-CD is characterized by Fourier Transform Infrared
Zhou, Lu, Wang, Yali, Li, Lu, Zou, Changjun   +3 more
core  

Pharmacokinetics and distribution of 2-hydroxypropyl-β-cyclodextrin following a single intrathecal dose to cats. [PDF]

J Inherit Metab Dis, 2020
Kao ML, Stellar S, Solon E, Lordi A, Kasica N, Swain G, Bagel JH, Gurda BL, Vite CH.   +8 more
europepmc   +1 more source

2-Hydroxypropyl-Β-Cyclodextrin Reduces Atherosclerotic Plaques in Human Coronary Artery

Cardiovascular and cerebral arterial disease has become the number 1 killer of human being. The main pathology is atherosclerotic plaque, characterised by the build-up of cholesterol in the inner lining of the arteries, which blocks blood flow.
Hodgetts, Kyle, Song, Zan-Min, Demian, Mark, Fang, Yu-Yan   +3 more
core   +1 more source

Nanoencapsulation of <i>Rhodiola rosea</i> extract into 2-hydroxypropyl-β-cyclodextrin: enhanced antibacterial and anticancer activities. [PDF]

RSC Adv
Khorshed S, Abdeldayem AM, Fritsche W, Azzazy HME.   +3 more
europepmc   +1 more source

A phase 1/2 open label nonrandomized clinical trial of intravenous 2-hydroxypropyl-β-cyclodextrin for acute liver disease in infants with Niemann-Pick C1. [PDF]

Mol Genet Metab Rep, 2021
Reynolds M, Linneman LA, Luna S, Warner BB, Turmelle YP, Kulkarni SS, Jiang X, Khanna G, Shinawi M, Porter FD, Ory DS, Cole FS, Dickson PI.   +12 more
europepmc   +1 more source

Enhancement of α-Mangostin Wound Healing Ability by Complexation with 2-Hydroxypropyl-β-Cyclodextrin in Hydrogel Formulation. [PDF]

Pharmaceuticals (Basel), 2020
Wathoni N, Sari DP, Suharyani I, Motoyama K, Mohammed AFA, Cahyanto A, Abdassah M, Muchtaridi M.   +7 more
europepmc   +1 more source

Inhibition of therapeutic protein aggregation by cyclodextrins [PDF]

, 2010
Serno, Tim
core  

Plasma Biomarker Profiling of 2-Hydroxypropyl-β-Cyclodextrin (HPβCD) Treatment in an Aged Mouse Model of Ischemic Stroke. [PDF]

Int J Mol Sci
Becktel DA, Frye JB, Le EH, Schnellmann RG, Doyle KP.   +4 more
europepmc   +1 more source